In 2010, a federal advisory committee — the Secretary's Advisory Committee on Heritable Disorders in Newborns and Children (SACHDNC) — wrote a public letter to the U.S. Department of Health and Human Services raising concerns about a sports policy that's still in effect today. The NCAA requires Division I athletes to be screened for sickle cell trait (SCT). Many high schools and athletic associations followed suit.
The committee's concern wasn't with screening itself. It was with the purpose of the screening, who carries the consequences, and what the alternative should have been.
Here's the substance — because this conversation matters as much in 2026 as it did then.
The committee's argument, simplified:
1. The science is mixed. Even after years of attention, it remains unclear how much sickle cell trait independently contributes to exercise-related sudden death. In many fatal cases reviewed, sickled cells were found at autopsy — but post-mortem sickling occurs after death from any cause in someone with SCT. That's a confounder.
2. The deaths in question were rare and largely preventable — for all athletes. Military studies showed that gradual exercise progression, hydration, and adequate rest cut exercise-related deaths across the board, regardless of trait status. Universal safe-training practices would protect everyone — without singling anyone out.
3. Singling out athletes by genetic status creates risk of stigma and discrimination. This is the heart of it. SCT is most common in Black and brown athletes. A screening program targeted at trait — without strong privacy protections, without educational support, and without changes in how everyone is trained — risks turning a genetic difference into a job-fitness label.
4. The right home for genetic screening is the medical home — not the locker room. Newborn screening already identifies SCT in nearly every American newborn since 2006. The problem isn't a lack of testing; it's a lack of follow-through. People deserve to know their status — but in the context of medical counseling, family planning conversations, and informed consent. Not as a precondition for a roster spot.
5. Genetic privacy laws (GINA) protect against discrimination in employment and health insurance — but not in athletics. That gap matters.
The committee's recommendations were direct:
- Universal safe-training guidelines for all athletes.
- Education for coaches and trainers on heat illness and exertional sickling.
- Genetic screening kept inside the medical home, with privacy and counseling built in.
- More research, not more single-group screening.
Where this leaves families today. You should know your sickle cell status. So should your kids. The right path is the same one the committee recommended in 2010: testing through your provider, with counseling, with privacy. When schools and teams ask for trait status, you have a right to ask in return: What does the team do with this information? Who has access? What changes about my child's training plan?
Knowledge belongs to you. Use it on your terms.
— Dr. Rob
📄 Resource: SACHDNC Letter to Secretary Sebelius on Athletic Screening for Sickle Cell Trait (June 14, 2010).